| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 664401 | Null | 0.0278435641331424 | 0.28538426 |
| NSC 667471 | Null | 0.0278435641331424 | 0.34168792 |
| NSC 670656 | 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer | 0.0278435641331424 | 0.22204729 |
| NSC 670804 | Null | 0.0278435641331424 | -0.16593373 |
| NSC 673828 | Null | 0.0278435641331424 | 0.24652626 |
| NSC 690266 | ANTINEOPLASTIC-690266 | 0.0278435641331424 | 0.28275665 |
| NSC 697140 | Null | 0.0278435641331424 | 0.32564048 |
| NSC 699222 | 2-Quinoxalinecarbonitrile, 7-(4-nitrophenyl)-3-[4-(4-nitrophenyl)-1-piperazinyl]-, 1,4-dioxide | 0.0278435641331424 | 0.10624566 |
| NSC 702208 | Spiro[benzo[1,2-b:5,4-c']dipyran-2(3H),2'(3'H)-naphtho[2,3- b]furan]-7-carboxylic acid, 3'-[(2,6-dideoxy-3-O-methylhexo pyranosyl)oxy]-4,5',8',9-tetrahydro-3,4',9',10-tetrahydroxy-7'-methoxy-5',8',9- | 0.0278435641331424 | 0.37022071 |
| NSC 287459 | Cytarabine AY | 0.0304779558345019 | 0.22671755 |